We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+4.26%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$2.27B
AUM Growth
+$198M
(+9.6%)
Cap. Flow
+$119M
Cap. Flow
% of AUM
5.25%
Top 10 Holdings %
Top 10 Hldgs %
35.16%
Holding
449
New
157
Increased
70
Reduced
62
Closed
148
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
RAI
Reynolds American Inc
RAI
|
+$84.2M |
| 2 |
Charter Communications
CHTR
|
+$83.5M |
| 3 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$56.6M |
| 4 |
Bank of America
BAC
|
+$43.5M |
| 5 |
Lowe's Companies
LOW
|
+$38.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zoetis
ZTS
|
+$170M |
| 2 |
T-Mobile US
TMUS
|
+$71.2M |
| 3 |
Advance Auto Parts
AAP
|
+$34.1M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$27.2M |
| 5 |
VAL
Valspar
VAL
|
+$22M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Staples | 15.94% |
| 2 | Healthcare | 14.24% |
| 3 | Communication Services | 13.98% |
| 4 | Consumer Discretionary | 11.95% |
| 5 | Technology | 9.98% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
Estee Lauder
EL
$29B
| $10M | 0.44% |
104,595
-56,157
| -35% | -$5.15M |
|
52
Morgan Stanley
MS
$337B
| $9.83M | 0.43% |
218,455
-225,633
| -51% | -$9.73M |
|
|
DDC
53
DELISTED
Dominion Diamond Corporation
DDC
| $9.8M | 0.43% |
+754,151
| New | +$9.59M |
|
|
NE
54
DELISTED
Noble Corporation
NE
| $9.51M | 0.42% |
2,377,944
+2,340,490
| +6,249% | +$10.8M |
|
|
FRC
55
DELISTED
First Republic Bank
FRC
| $9.44M | 0.42% |
94,390
-207
| -0.2% | -$19.6K |
|
|
WFT
56
DELISTED
Weatherford International plc
WFT
| $9.38M | 0.41% |
2,344,905
+2,267,371
| +2,924% | +$11.5M |
|
57
Air Products & Chemicals
APD
$66.3B
| $8.89M | 0.39% |
62,175
+46,444
| +295% | +$6.6M |
|
58
Molson Coors Class B
TAP
$7.68B
| $8.03M | 0.35% |
93,351
+70,724
| +313% | +$6.55M |
|
|
PARA
59
DELISTED
Paramount Global Class B
PARA
| $8.02M | 0.35% |
125,350
-54,998
| -30% | -$3.52M |
|
60
Arch Capital
ACGL
$36.1B
| $7.6M | 0.33% |
245,184
+13,845
| +6% | +$439K |
|
|
CDK
61
DELISTED
CDK Global, Inc.
CDK
| $7.2M | 0.32% |
116,048
+6,485
| +6% | +$407K |
|
|
TGP
62
DELISTED
Teekay LNG Partners L.P.
TGP
| $7.17M | 0.32% |
477,963
-17,736
| -4% | -$286K |
|
|
LSXMK
63
DELISTED
Liberty Media Corporation Series C Liberty SiriusXM Common Stock
LSXMK
| $7.17M | 0.32% |
224,056
-13,513
| -6% | -$405K |
|
64
Colgate-Palmolive
CL
$72.6B
| $7.09M | 0.31% |
95,815
+14,736
| +18% | +$1.09M |
|
65
PNC Financial Services
PNC
$100B
| $6.98M | 0.31% |
55,872
-14,926
| -21% | -$1.8M |
|
66
AstraZeneca
AZN
$263B
| $6.92M | 0.3% |
+101,717
| New | +$6.64M |
|
67
Autoliv
ALV
$8.6B
| $6.89M | 0.3% |
86,914
+4,907
| +6% | +$372K |
|
|
ISBC
68
DELISTED
Investors Bancorp, Inc.
ISBC
| $6.86M | 0.3% |
527,924
+29,802
| +6% | +$408K |
|
|
OPLN
69
Openlane
OPLN
$4.17B
| $6.76M | 0.3% |
425,156
+3,289
| +0.8% | +$53.6K |
|
70
Huntsman Corp
HUN
$2.24B
| $6.66M | 0.29% |
+256,092
| New | +$6.34M |
|
|
NYRT
71
DELISTED
New York REIT, Inc.
NYRT
| $6.64M | 0.29% |
73,808
+60,292
| +446% | +$5.47M |
|
|
PLYA
72
DELISTED
Playa Hotels & Resorts
PLYA
| $6.6M | 0.29% |
+549,996
| New | +$5.8M |
|
73
Pfizer
PFE
$140B
| $6.42M | 0.28% |
199,016
+144,204
| +263% | +$4.55M |
|
74
Vertex Pharmaceuticals
VRTX
$121B
| $6.3M | 0.28% |
+48,832
| New | +$5.88M |
|
75
Waste Management
WM
$95.9B
| $6.25M | 0.28% |
+85,557
| New | +$6.23M |
|
Similar funds
Marshall Wace's Q2 2017 Portfolio in Review
As of Q2 2017, Marshall Wace held 449 positions worth $2.27B, up 9.6% from $2.07B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Marshall Wace deployed $119M of net new capital in Q2 2017, opening 157 new positions and adding to 70 existing holdings. Its largest new stake was State Street Health Care Select Sector SPDR ETF: 742,458 shares worth $58.7M.
By sector, the portfolio is most concentrated in Consumer Staples at 16% of assets, up from 11% a quarter earlier, followed by Healthcare and Communication Services.
On the sell side, the largest reduction was Zoetis, an estimated $170M trimmed.
- Marshall Wace's largest Q2 2017 buy was State Street Health Care Select Sector SPDR ETF: 742,458 shares worth $58.7M.
- Marshall Wace added most to Reynolds American Inc in Q2 2017, an estimated $84.2M increase.
- Marshall Wace's biggest Q2 2017 reduction was Zoetis, cutting an estimated $170M.
- Marshall Wace fully exited Advance Auto Parts in Q2 2017, selling an estimated $34.1M.
- Marshall Wace's ten largest holdings make up 35% of its $2.27B portfolio in Q2 2017.
- Marshall Wace opened 157 new positions and closed 148 in Q2 2017.
- Marshall Wace's portfolio value rose 9.6% quarter-over-quarter to $2.27B.
Based on Marshall Wace's 13F filing for Q2 2017, filed 4 Aug 2017.